Verrucous Venous Malformation
Conditions
Interventions
group 1:topical sirolimus
Sponsors
Shanghai Ninth People's Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients with verrucous venous malformation who came to the outpatient department of our hospital from Nov. 2021 to June 2022 had no complications such as ulcers, infection, and bleeding on the surface of the lesions; 2. Diffuse lesions; 3. Patients who have not received oral sirolimus treatment before the initial diagnosis, and have not received laser or external drug treatment at the lesion; 4. Those who are willing to accept and cooperate with examination and treatment, and who can follow up regularly.
Exclusion criteria
Exclusion criteria: 1. The patient has severe immunodeficiency or congenital disease; 2. Pregnant patients and the elderly (> 65 years old); 3. Patients with severe keratinization at the lesion, which cannot be treated by drugs or lasers, or the lesion has affected the function of the limbs and other patients who need surgical resection; 4. Those who are participating in other clinical trials; 5. Those who are allergic to sirolimus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale; | — |
Countries
China
Contacts
Public ContactLin Xiaoxi
Outcome results
None listed